Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance
Open accessThe DOI matches its Crossref record; 71 of the 73 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
As a metabolic center, the liver prevents inappropriate immune responses to abundant dietary antigens within the liver that could result in liver injury. This self-preservation mechanism can however decrease the efficiency of immunosurveillance of malignant cells by CD8 T cells. Hepatocellular carcinoma (HCC) is initiated by chronic viral infections, chronic alcohol consumption, and/or a fatty diet that leads to liver injury, fibrosis, and cirrhosis. HCC patients have high levels of dysfunctional and exhausted T cells, however, it is unclear which stage of HCC development contributes to T cell dysfunction. Repair of liver injury is initiated by interactions between injured hepatocytes and liver sinusoidal endothelial cells (LSEC), however, chronic injury can lead to fibrosis. Here, using a diethylnitrosamine/carbon tetrachloride (DEN/CCl 4) mouse model of early HCC development, we demonstrate that chronic liver injury and fibrosis are sufficient to induce a CD8 T cell exhaustion signature with a corresponding increase in expression of immunosuppressive molecules on LSEC. We show that LSEC alter T cell function at various stages of T cell differentiation/activation. LSEC compete with dendritic cells presenting the same antigen to naïve CD8 T cells resulting in a unique T cell phenotype. Furthermore, LSEC abrogate killing of target cells, in an antigen-dependent manner, by previously activated effector CD8 T cells, and LSEC change the effector cell cytokine profile. Moreover, LSEC induce functional T cell exhaustion under low dose chronic stimulation conditions. Thus, LSEC critically regulate the balance between preventing/limiting liver injury and permitting sufficient tumor immunosurveillance with normal hepatic functions likely contributing to HCC development under conditions of chronic liver insult.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, LSECs alter the DC-mediated activation of T cells, inhibit CD8+ T-cell cytotoxicity, and promote T-cell exhaustion in a mouse model of early HCC development [330].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [330]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Ahmadzadeh, M., Johnson, L. A., Heemskerk, B., Wunderlich, J. R., Dudley, M. E., White, D. E., & Rosenberg, S. A. (2009) · Blood · doi:10.1182/blood-2008-12-195792 · Cited by 1,766
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Raskov, H., Orhan, A., Christensen, J. P., & Gögenur, I. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01048-4 · Cited by 1,687
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
CD8+ T Cells: Foot Soldiers of the Immune System
Zhang, N., & Bevan, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.010 · Cited by 1,088
Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758
CD8+ T Cell Exhaustion in Cancer
Dolina, J. S., Van Braeckel-Budimir, N., Thomas, G. D., & Salek-Ardakani, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715234 · Cited by 489
Mechanisms regulating PD-L1 expression on tumor and immune cells
Chen, S., Crabill, G. A., Pritchard, T. S., McMiller, T. L., Wei, P., Pardoll, D. M., Pan, F., & Topalian, S. L. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0770-2 · Cited by 459
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 429
T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance
Ye, B., Liu, X., Li, X., Kong, H., Tian, L., & Chen, Y. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.42 · Cited by 391
Wu, K., Kryczek, I., Chen, L., Zou, W., & Welling, T. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0901 · Cited by 380
Ma, J., Zheng, B., Goswami, S., Meng, L., Zhang, D., Cao, C., Li, T., Zhu, F., Ma, L., Zhang, Z., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0814-7 · Cited by 360
Warren, A., Le Couteur, D. G., Fraser, R., Bowen, D. G., McCaughan, G. W., & Bertolino, P. (2006) · Hepatology · doi:10.1002/hep.21378 · Cited by 347
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
You, Q., Cheng, L., Kedl, R. M., & Ju, C. (2008) · Hepatology · doi:10.1002/hep.22395 · Cited by 331
Immunosurveillance of the Liver by Intravascular Effector CD8 + T Cells
Guidotti, L. G., Inverso, D., Sironi, L., Di Lucia, P., Fioravanti, J., Ganzer, L., Fiocchi, A., Vacca, M., Aiolfi, R., Sammicheli, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.005 · Cited by 323
Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice
Tolba, R., Kraus, T., Liedtke, C., Schwarz, M., & Weiskirchen, R. (2015) · Laboratory Animals · doi:10.1177/0023677215570086 · Cited by 313
Horst, A. K., Neumann, K., Diehl, L., & Tiegs, G. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.112 · Cited by 295
Diehl, L., Schurich, A., Grochtmann, R., Hegenbarth, S., Chen, L., & Knolle, P. A. (2008) · Hepatology · doi:10.1002/hep.21965 · Cited by 291
Selective Retention of Activated CD8+ T Cells by the Normal Liver
Mehal, W. Z., Juedes, A. E., & Crispe, I. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3202 · Cited by 254
Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
Brown, Z. J., Heinrich, B., & Greten, T. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0033-6 · Cited by 245
Mueller, S. N., Matloubian, M., Clemens, D. M., Sharpe, A. H., Freeman, G. J., Gangappa, S., Larsen, C. P., & Ahmed, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702579104 · Cited by 234
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
Ge, Z., Peppelenbosch, M. P., Sprengers, D., & Kwekkeboom, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.699895 · Cited by 231
Knolle, P. A., Uhrig, A., Hegenbarth, S., Löser, E., Schmitt, E., Gerken, G., & Lohse, A. W. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00713.x · Cited by 203
Immunological functions of liver sinusoidal endothelial cells
Knolle, P. A., & Wohlleber, D. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.5 · Cited by 199
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma
Barsch, M., Salié, H., Schlaak, A. E., Zhang, Z., Hess, M., Mayer, L. S., Tauber, C., Otto-Mora, P., Ohtani, T., Nilsson, T., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.02.032 · Cited by 186
Dendritic cells and immune regulation in the liver
Lau, A. H. (2003) · Gut · doi:10.1136/gut.52.2.307 · Cited by 183
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
Schneider, C., Teufel, A., Yevsa, T., Staib, F., Hohmeyer, A., Walenda, G., Zimmermann, H. W., Vucur, M., Huss, S., Gassler, N., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301116 · Cited by 182
McNamara, H. A., Cai, Y., Wagle, M. V., Sontani, Y., Roots, C. M., Miosge, L. A., O’Connor, J. H., Sutton, H. J., Ganusov, V. V., Heath, W. R., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aaj1996 · Cited by 181
Endotoxin Down-Regulates T Cell Activation by Antigen-Presenting Liver Sinusoidal Endothelial Cells
Knolle, P. A., Germann, T., Treichel, U., Uhrig, A., Schmitt, E., Hegenbarth, S., Lohse, A. W., & Gerken, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1401 · Cited by 180
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway
Chen, T., Dai, X., Dai, J., Ding, C., Zhang, Z., Lin, Z., Hu, J., Lu, M., Wang, Z., Qi, Y., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03030-7 · Cited by 168
Uehara, T., Pogribny, I. P., & Rusyn, I. (2014) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1430s66 · Cited by 156
Transcriptome Profiling Identifies TIGIT as a Marker of T‐Cell Exhaustion in Liver Cancer
Ostroumov, D., Duong, S., Wingerath, J., Woller, N., Manns, M. P., Timrott, K., Kleine, M., Ramackers, W., Roessler, S. K., Nahnsen, S., et al. (2021) · Hepatology · doi:10.1002/hep.31466 · Cited by 132
Lanaspa, M. A., Andres-Hernando, A., Orlicky, D. J., Cicerchi, C., Jang, C., Li, N., Milagres, T., Kuwabara, M., Wempe, M. F., Rabinowitz, J. D., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94427 · Cited by 125
Self-citationDynamic Regulation of CD8 T Cell Tolerance Induction by Liver Sinusoidal Endothelial Cells
Schurich, A., Berg, M., Stabenow, D., Böttcher, J., Kern, M., Schild, H.-J., Kurts, C., Schuette, V., Burgdorf, S., Diehl, L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902580 · Cited by 124
The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver
Wilkinson, A. L., Qurashi, M., & Shetty, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00990 · Cited by 121
Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen‐presenting dendritic cells
Schildberg, F. A., Hegenbarth, S. I., Schumak, B., Limmer, A., & Knolle, P. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200738060 · Cited by 116
Roles of hepatic stellate cells in liver inflammation: a new perspective
Fujita, T., & Narumiya, S. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0005-6 · Cited by 113
Li, D., Sedano, S., Allen, R. S., Gong, J., Cho, M. T., & Sharma, S. (2019) · Cancers · doi:10.3390/cancers11060841 · Cited by 110
TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy
McLoughlin, M. R., Orlicky, D. J., Prigge, J. R., Krishna, P., Talago, E. A., Cavigli, I. R., Eriksson, S., Miller, C. G., Kundert, J. A., Sayin, V. I., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903244116 · Cited by 108
Self-citationIn vitro modeling of CD8 + T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40
Wu, J. E., Manne, S., Ngiow, S. F., Baxter, A. E., Huang, H., Freilich, E., Clark, M. L., Lee, J. H., Chen, Z., Khan, O., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade3369 · Cited by 108
von Oppen, N., Schurich, A., Hegenbarth, S., Stabenow, D., Tolba, R., Weiskirchen, R., Geerts, A., Kolanus, W., Knolle, P., & Diehl, L. (2009) · Hepatology · doi:10.1002/hep.22795 · Cited by 101
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Thompson, A. I., Conroy, K. P., & Henderson, N. C. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0291-5 · Cited by 100
Lebossé, F., Gudd, C., Tunc, E., Singanayagam, A., Nathwani, R., Triantafyllou, E., Pop, O., Kumar, N., Mukherjee, S., Hou, T. Z., et al. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.10.011 · Cited by 100
Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism
Schildberg, F. A., Wojtalla, A., Siegmund, S. V., Endl, E., Diehl, L., Abdullah, Z., Kurts, C., & Knolle, P. A. (2011) · Hepatology · doi:10.1002/hep.24352 · Cited by 90
Brandon‐Warner, E., Walling, T. L., Schrum, L. W., & McKillop, I. H. (2012) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01660.x · Cited by 88
Ge, Z., Zhou, G., Campos Carrascosa, L., Gausvik, E., Boor, P. P. C., Noordam, L., Doukas, M., Polak, W. G., Terkivatan, T., Pan, Q., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.03.003 · Cited by 87
Angiocrine signaling in the hepatic sinusoids in health and disease
Kostallari, E., & Shah, V. H. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00118.2016 · Cited by 71
Höchst, B., Schildberg, F. A., Böttcher, J., Metzger, C., Huss, S., Türler, A., Overhaus, M., Knoblich, A., Schneider, B., Pantelis, D., et al. (2012) · Hepatology · doi:10.1002/hep.25844 · Cited by 62
Combination of CCl4 with alcoholic and metabolic injuries mimics human liver fibrosis
Brol, M. J., Rösch, F., Schierwagen, R., Magdaleno, F., Uschner, F. E., Manekeller, S., Queck, A., Schwarzkopf, K. M., Odenthal, M., Drebber, U., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00361.2018 · Cited by 62
Du, W., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936196 · Cited by 56
Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy
Zhang, C.-Y., Liu, S., & Yang, M. J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i27.3346 · Cited by 55
Lee, G.-H., Nomura, K., & Kitagawa, T. (1989) · Carcinogenesis · doi:10.1093/carcin/10.12.2227 · Cited by 52
Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
Méndez‐Sánchez, N., Córdova‐Gallardo, J., Barranco-Fragoso, B., & Eslam, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641240 · Cited by 52
LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation
Kremer, K. N., Buser, A. E., Thumkeo, D., Narumiya, S., Jacobelli, J., Pelanda, R., & Torres, R. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118816119 · Cited by 45
Self-citationMonks, J., Orlicky, D. J., Stefanski, A. L., Libby, A. E., Bales, E. S., Rudolph, M. C., Johnson, G. C., Sherk, V. D., Jackman, M. R., Williamson, K., et al. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0027-z · Cited by 44
Self-citationUehara, T., Pogribny, I. P., & Rusyn, I. (2021) · Current Protocols · doi:10.1002/cpz1.211 · Cited by 44
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury
Hackstein, C.-P., Spitzer, J., Symeonidis, K., Horvatic, H., Bedke, T., Steglich, B., Klein, S., Assmus, L. M., Odainic, A., Szlapa, J., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.026 · Cited by 39
Weghorst, C. M., Pereira, M. A., & Klaunig, E. J. (1989) · Carcinogenesis · doi:10.1093/carcin/10.8.1409 · Cited by 38
Alirzayeva, E. H., Neumann, G., Horst, W. J., Allahverdiyeva, Y., Specht, A., & Alizade, V. М. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.11.041 · Cited by 38
Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
Liu, S., Huang, F., Ru, G., Wang, Y., Zhang, B., Chen, X., & Chu, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.902820 · Cited by 36
Molecular insight into T cell exhaustion in hepatocellular carcinoma
Zhu, Y., Tan, H., Wang, J., Zhuang, H., Zhao, H., & Lu, X. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107161 · Cited by 30
Qiu, B., Wang, J., Yu, Y., Chao, Z., Gu, J., Liu, W., Wen, Y., Chen, L., Gao, Y., Xia, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14293 · Cited by 30
Romualdo, G. R., Bacil, G. P., da Silva, T. C., Fernandes, A. A. H., Moreno, F. S., Cogliati, B., & Barbisan, L. F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203879 · Cited by 28
Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in Mice
Yi, X., Li, L., Yang, C., Lu, Y., & Cheng, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093599 · Cited by 25
Wei, Y., Fan, J., Shan, M., Yin, D., Wang, L., Ye, W., & Zhao, W. (2022) · PubMed Central · Cited by 22
New insights into T-cell exhaustion in liver cancer: from mechanism to therapy
Hao, L., Li, S., & Hu, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05083-5 · Cited by 17
Kaczmarek, J., Homsi, Y., van Üüm, J., Metzger, C., Knolle, P. A., Kolanus, W., Lang, T., & Diehl, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099574 · Cited by 15
Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells
Finlon, J. M., Burchill, M. A., & Tamburini, B. A. J. (2019) · Journal of Visualized Experiments · doi:10.3791/58621-v · Cited by 5
Disrupting Poly(ADP-ribosyl)ating Pathway Creates Premalignant Conditions in Mammalian Liver
Karpova, Y. D., Orlicky, D. J., Schmidt, E. E., & Tulin, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417205 · Cited by 1
Self-citation
Research works printed but not linked: 1
- Jepsen P, Vilstrup H, Tarone RE, Friis S, Sorensen HT. Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends. Int J Cancer. (2007) 121:1624-6. doi: 10.1002/ijc.v121:7 · doi:10.1002/ijc.v121:7
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“In addition, LSECs alter the DC-mediated activation of T cells, inhibit CD8 + T-cell cytotoxicity, and promote T-cell exhaustion in a mouse model of early HCC development [330].”
Li, Y., Huan, C., Sun, H., Zhang, W., Guo, Z., Li, C., Yao, J., Zhang, Z., Yu, S., Dong, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202514661 · Cited by 50
Wu, S., Anand, N., Guo, Z., Li, M., Figueroa, M. S., Jung, L., Kelly, S., & Franses, J. W. (2025) · Cancers · doi:10.3390/cancers17111860 · Cited by 31
“These vascular abnormalities impair immune cell infiltration and reinforce immunosuppressive signaling [21,22].”
Abdulmajeed, R. J., & Sergi, C. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168006 · Cited by 16
“A promising treatment strategy for correcting liver fibrosis and improving liver regeneration has been shown to involve drugs which target the capillarization of LSECs [16,48].”
Hepatic Fibrosis and Liver Cancer
Anton, A., Friedman, S. L., & Cogliati, B. (2025) · Seminars in Liver Disease · doi:10.1055/a-2779-4937 · Cited by 11
Metadata
- Authors
- Kremer, K. N., Khammash, H. A., Miranda, A. M., Rutt, L. N., Twardy, S. M., Anton, P. E., Campbell, M. L., Garza-Ortiz, C., Orlicky, D. J., Pelanda, R., McCullough, R. L., & Torres, R. M.
- Affiliations
- University of Colorado Anschutz (US)
- Corresponding author
- Kremer, Kimberly N.
- Torres, Raul M.
- ORCID
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2025-01-17
- Volume
- 15
- Pages
- 1497788-1497788
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC11782242
- OpenAlex
- W4406543123
- Cited by
- 19
- References
- 73
- Citations by year
- 2026: 10 · 2025: 9
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (AA029234 , AI143261, AA030741, ES032529, AI152535, AI156232, CA06934)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- liver sinusoidal endothelial cells, hepatocellular carcinoma, CD8+ T cell exhaustion, tumor surveillance, chronic liver injury, liver fibrosis, dendritic cells, T cell activation, T cell cytokine profile, liver injury repair
- MeSH terms
- Animals, Carbon Tetrachloride, Dendritic Cells, Diethylnitrosamine, Disease Models, Animal, Carcinoma, Hepatocellular, Immune Tolerance, Immunologic Surveillance, Liver, Liver Cirrhosis, Liver Neoplasms, Lymphocyte Activation, Male, Mice, Inbred C57BL, CD8-Positive T-Lymphocytes, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.